HistoSonics, Inc.

HistoSonics is a medical device company dedicated to advancing the novel science of histotripsy. Histotripsy is a non-invasive, focused ultrasound therapy that uses high amplitude, short pulses to create “bubble clouds” which destroy targeted tissue at a sub-cellular level. HistoSonics has developed the Edison System, a platform that delivers pulsed sound energy into the body to destroy tumors without the need for incisions or needles. The company is currently focused on commercializing the Edison System for the treatment of liver tumors in the United States and select global markets, while expanding histotripsy applications into other organs like kidney, pancreas, prostate, brain, and others.

HistoSonics is committed to supporting clinical research and has an Investigator-Sponsored Research (ISR) program that provides financial support for studies using the Edison System. They also have a comprehensive education program to train medical professionals on the use of the Edison System. HistoSonics has secured significant funding and has partnerships with leading institutions around the world to develop multi-disciplinary histotripsy programs. The company is working to redefine the treatment landscape for a variety of challenging clinical conditions, offering patients improved outcomes and recovery times.

HistoSonics is a medical device company dedicated to advancing the novel science of histotripsy and its powerful benefits. Their mission is to bring meaningful and transformational change to physicians and patients by developing non-invasive platforms and proprietary sonic beam therapy that utilizes the science of histotripsy, a novel mechanism of action that uses focused ultrasound to mechanically destroy and liquefy unwanted tissue and tumors.

HistoSonics promotes a culture focused on innovation and collaboration. They highlight their team's dedication to advancing the science of histotripsy, bringing together leading researchers and clinicians to bring this revolutionary technology to patients. The company's emphasis on education and partnerships with academic institutions and medical professionals further underscores their commitment to a collaborative and knowledge-driven environment.